M.-L. Teyssot, M. Fayolle, C. Philouze, C. Dupuy
FULL PAPER
(s, 4 H), 3.02 (t, J ϭ 5.45 Hz, 4 H), 3.68 (m, 8 H), 7.23Ϫ7.31 (m, 1022, 741, 703 (CHAr) cmϪ1. MS (DCI, NH3/isobutane): m/z
3
10 H) ppm. 13C NMR (75.47 MHz, CDCl3): δ ϭ 52.3, 55.0, 55.3,
63.4, 127.4, 128.4, 129.4, 138.3 ppm. IR: ν˜ ϭ 3096, 3073, 3012
(%) ϭ 625 (100) [M ϩ H]ϩ. C38H48N4O2S (624.9) ϩ H2O: calcd.
C 70.99, H 7.84, N 8.71, S 4.99; found C 71.35, H 7.76, N 8.44,
(CHAr), 2921, 2822 (CH), 1272 (SO2), 1219, 1136 (SO2), 1113, 711, S 4.74.
680 (CHAr) cmϪ1. MS (DCI, NH3/isobutane): m/z (%) ϭ 359 (100)
7,13-Dibenzyl-1,4-dioxa-10-thia-7,13-diazacyclopentadecane 10,10-
[M ϩ H]ϩ. C20H26N2O2S (358.5): calcd. C 67.01, H 7.31, N 7.81,
Dioxide (6a): Diamine 6 (328 mg, 1 mmol) and DVS (118 mg,
1 mmol) were refluxed overnight. After purification by column
chromatography (cyclohexane/ethyl acetate, 5:5), macrocycle 6a
S 8.94; found C 66.57, H 7.36, N 7.80, S 8.68.
4,8-Dibenzyl-1-thia-4,8-diazacyclodecane 1,1-Dioxide (2a):
2
1
(510 mg, 2 mmol) and DVS (236 mg, 2 mmol) were refluxed over-
was isolated as a yellow oil (245 mg, 0.55 mmol, 55%). H NMR
3
night and the macrocycle 2a was isolated by column chromato-
(300 MHz, CDCl3): δ ϭ 2.66 (t, J ϭ 4.5 Hz, 4 H), 3.15Ϫ3.32 (m,
graphy (CHCl3/MeOH, 99.9:0.1) as translucent crystals (680 mg, 8 H), 3.51 (t, 3J ϭ 4.5 Hz, 4 H), 3.55 (s, 4 H), 3.66 (s, 4 H),
1.82 mmol, 91%). M.p. 143Ϫ144 °C. 1H NMR (300 MHz, CDCl3): 7.26Ϫ7.33 (m, 10 H) ppm. 13C NMR (75.47 MHz, CDCl3): δ ϭ
3
δ ϭ 1.39 (quint, 2 H, J ϭ 6.0 Hz), 2.49 (br. s, 4 H), 2.88 (br. s, 4
48.2, 52.1, 53.3, 60.0, 70.3, 70.5, 127.2, 128.3, 128.8, 138.6 ppm.
IR: ν˜ ϭ 3088, 3020 (CHAr), 2929, 2853 (CH), 1455, 1371, 1288,
H), 3.24 (br. s, 4 H), 3.57 (s, 4 H), 7.22Ϫ7.32 (m, 10 H) ppm. 13C
NMR (75.47 MHz, CDCl3): δ ϭ 23.4, 48.0, 50.2, 52.7, 59.9, 127.5, 1121 (SO2), 1068, 749, 711 (CHAr) cmϪ1. MS (DCI, NH3/
128.4, 129.7, 137.2 ppm. IR: ν˜ ϭ 3063, 3028 (CHAr), 2976, 2920,
isobutane): m/z (%) ϭ 447 (100) [M ϩ H]ϩ. C24H34N2O4S (446.6):
calcd. C 64.54, H 7.67, N 6.27, S 7.18; found C 64.80, H 7.89, N
6.27, S 7.37.
2802 (CH), 1500, 1450, 1282, 1128 (SO2), 889, 748 (CHAr) cmϪ1
.
MS (DCI, NH3/isobutane): m/z (%) ϭ 109 (11) [BnNH4]ϩ, 282 (13)
[M Ϫ Bn ϩ H]ϩ, 373 (100) [M ϩ H]ϩ. C21H28N2O2S (372.5): calcd.
C 67.71, H 7.58, N 7.52, S 8.61; found C 67.71, H 7.59, N 7.60,
S 8.65.
1,4-Dioxa-10-thia-7,13-diazacyclopentadecane 10,10-Dioxide (6b):
6a (154 mg, 0.35 mmol) in ethanol (10 mL) was added to a suspen-
sion of 10% Pd/C (30 mg) in THF (10 mL) and the reaction mix-
ture was stirred for 2 d at room temperature under H2. The solution
4,7,10-Tribenzyl-1-thia-4,7,10-triazacyclododecane 1,1-Dioxide (3a):
Triamine 3 (374 mg, 1 mmol) was refluxed with DVS (118 mg, was filtered through Celite and reduced to dryness. The residue was
1 mmol) overnight. 3a was obtained after purification by column taken up in water (20 mL) and washed with diethyl ether (3 ϫ
chromatography (CHCl3/MeOH/NH4OH, 99:0.5:0.05) as a pale 10 mL). Solvent evaporation afforded pure 6b (90 mg, 0.34 mmol,
yellow oil (440 mg, 0.9 mmol, 90%). 1H NMR (300 MHz, CDCl3):
98%) as a pale yellow oil. 1H NMR (300 MHz, CDCl3): δ ϭ
3
3
δ ϭ 2.49Ϫ2.59 (m, 8 H), 3.08 (t, J ϭ 6.3 Hz, 4 H), 3.37 (t, J ϭ 2.76Ϫ2.80 (m, 6 H), 3.13 (t, 3J ϭ 5.5 Hz, 4 H), 3.40 (t, 3J ϭ 5.5 Hz,
6.3 Hz, 4 H), 3.44 (s, 2 H), 3.54 (s, 4 H), 7.22Ϫ7.29 (m, 15 H) ppm. 4 H), 3.62 (s, 4 H), 3.63 (m, 4 H) ppm. 13C NMR (75.47 MHz,
13C NMR (75.47 MHz, CDCl3): δ ϭ 48.7, 51.8, 52.1, 53.0, 58.8, CDCl3): δ ϭ 43.7, 49.0, 54.4, 69.7, 70.2 ppm. IR: ν˜ ϭ 3362 (NH),
60.3, 127.1, 127.3, 128.2, 128.3, 129.2, 129.6, 138.1, 138.4 ppm. IR:
2952, 2830 (CH), 1668, 1455, 1409, 1288, 1120 (SO2), 1030 cmϪ1
MS (DCI, NH3/isobutane): m/z (%) 149 (4)
.
ν˜ ϭ 3080, 3020 (CHAr), 2959, 2800 (CH), 1470, 1380, 1288, 1128
ϭ
(SO2), 741, 703 (CHAr) cmϪ1. MS (DCI, NH3/isobutane): m/z [(H2NCH2CH2OCH2)2 ϩ H]ϩ, 267 (100) [M ϩ H]ϩ. C25H34N4O4S
(%) ϭ 91 (100) [Bn]ϩ, 492 (53) [M ϩ H]ϩ. C29H37N3O2S (491.7) ϩ (266.4) ϩ 1/2 H2O: calcd. C 43.62, H 8.42, N 10.17; found C 43.70,
3/2 H2O: calcd. C 67.15, H 7.77, N 8.10, S 6.18; found C 66.97, H
7.21, N 7.95, S 6.23.
H 8.23, N 10.00.
4,13-Dibenzyl-8,9-dioxo-1-thia-4,7,10,13-tetraazacyclopentadecane
4,10-Dibenzyl-1-oxa-7-thia-4,10-diazacyclododecane
7,7-Dioxide
1,1-Dioxide (7a): DVS (118 mg, 1 mmol) was added to compound
(4a): DVS (118 mg, 1 mmol) was added to diamine 4 (284 mg, 7 (354 mg, 1 mmol) and the reaction mixture was stirred at reflux
1 mmol) and the reaction mixture was refluxed for 1 h. Purification overnight. Purification of the residue by column chromatography
by column chromatography (cyclohexane/ethyl acetate, 7:3; Et3N
(CH2Cl2/MeOH, 99:1) afforded macrocycle 7a (174 mg, 0.37 mmol,
1%) yielded 4a as a white solid (241 mg, 0.6 mmol, 60%). M.p.
37%) as a white solid. M.p. Ͼ 220 °C. 1H NMR (300 MHz,
3
73Ϫ74 °C. 1H NMR (300 MHz, CDCl3): δ ϭ 2.67 (t, J ϭ 4.4 Hz, CDCl3): δ ϭ 2.66Ϫ2.69 (m, 4 H), 2.89 (s, 8 H), 3.28Ϫ3.34 (m, 4
3
3
3
4 H), 3.14 (ps t, 4 H, J ϭ 6.4, J ϭ 6.9 Hz), 3.29 (ps t, 4 H, J ϭ
6.4, 3J ϭ 6.9 Hz), 3.37 (t, 3J ϭ 4.4 Hz, 4 H), 3.69 (s, 4 H), ppm. 13C NMR (75.47 MHz, CDCl3): δ ϭ 38.0, 48.1, 52.9, 53.5,
7.26Ϫ7.33 (m, 10 H) ppm. 13C NMR (75.47 MHz, CDCl3): δ ϭ
59.8, 127.7, 128.6, 129.3, 137.7, 160.6 ppm. IR: ν˜ ϭ 3290 (NH),
H), 3.70 (s, 4 H), 7.25Ϫ7.36 (m, 10 H), 7.65 (br. t, 2 H, 3J ϭ 6.5 Hz)
50.1, 51.3, 53.9, 61.3, 70.6, 127.3, 128.3, 129.0, 138.4 ppm. IR: ν˜ ϭ 3077 (CHAr), 2979, 2922, 2832 (CH), 1649 (CO), 1543 (NH), 1453,
3096, 3058, 3027 (CHAr), 2936, 2890 (CH), 1515, 1455, 1364, 1303 1338, 1136 (SO2), 751, 710 (CHAr) cmϪ1. MS (DCI, NH3/
(SO2), 1258, 1151 (SO2), 1120 (CϪO), 1113, 1060, 817, 741, 696
isobutane): m/z (%) ϭ 473 (100) [M ϩ H]ϩ. C24H32N4O4S (472.6):
calcd. C 60.99, H 6.82, N 11.86, S 6.78; found C 60.96, H 6.76, N
(CHAr) cmϪ1. MS (DCI, NH3/isobutane): m/z (%) ϭ 313 (11) [M
Ϫ Bn ϩ 2 H]ϩ, 403 (100) [M ϩ H]ϩ. C22H30N2O3S (402.6): calcd. 11.63, S 6.98.
C 65.64, H 7.51, N 6.96, S 7.97; found C 65.34, H 7.39, N 6.89,
S 7.90.
4,14-Dibenzyl-8,10-dioxo-1-thia-4,7,11,14-tetraazacyclohexadecane
1,1-Dioxide (8a): Reaction of compound 8 (370 mg, 1 mmol) and
DVS (118 mg, 1 mmol) was completed in 2 h. Purification by col-
umn chromatography (CHCl3/MeOH/NH4OH, 98:2:0.1 to
95:5:0.4) yielded macrocycle 8a as a pale yellow oil (460 mg,
4,7,10,13-Tetrabenzyl-1-thia-4,7,10,13-tetraazacyclopentadecane
1,1-Dioxide (5a): Reaction of tetraamine 5 (250 mg, 0.5 mmol) and
DVS (59 mg, 0.5 mmol) was completed in 1.5 h. Column chromato-
1
3
graphy (cyclohexane/ethyl acetate, 7:3 to 5:5) yielded 5a as a yellow 0.94 mmol, 94%). H NMR (300 MHz, CDCl3): δ ϭ 2.59 (t, J ϭ
1
oil (230 mg, 0.37 mmol, 74%). H NMR (300 MHz, CDCl3): δ ϭ 5.3 Hz, 4 H), 2.94 (ps t, 4 H), 3.05 (ps t, 4 H), 3.14 (s, 2 H), 3.36
2.61Ϫ2.64 (m, 12 H), 3.0 (t, 3J ϭ 6.7 Hz, 4 H), 3.22 (t, 3J ϭ 6.7 Hz, (q, J ϭ 5.5 Hz, 4 H), 3.60 (s, 4 H), 7.22 (m, 10 H), 7.37Ϫ7.40 (m,
3
4 H), 3.43 (s, 4 H), 3.54 (s, 4 H), 7.21Ϫ7.29 (m, 20 H) ppm. 13C
NMR (75.47 MHz, CDCl3): δ ϭ 48.1, 52.1, 52.2, 52.25, 52.3, 59.3,
2 H) ppm. 13C NMR (75.47 MHz, CDCl3): δ ϭ 37.1, 44.4, 47.3,
52.3, 52.5, 58.7, 127.4, 128.4, 129.1, 137.5, 167.1 ppm. IR: ν˜ ϭ 3347
59.6, 126.9, 127.3, 128.1, 128.3, 129.0, 129.1, 138.1, 139.2 ppm. IR: (NH), 3096, 3073, 3035 (CHAr), 2936, 2830 (CH), 1675 (CO), 1546
ν˜ ϭ 3090, 3029 (CHAr), 2997, 2830 (CH), 1455, 1310, 1136 (SO2),
(NH), 1455, 1296, 1128 (SO2), 1068, 923, 741 (CHAr) cmϪ1. MS
60
Eur. J. Org. Chem. 2003, 54Ϫ62